From: Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
NEONet
Real-life
p-value
Drop-out
31.67Â %
17.50Â %
0.0000
Patient decision
48.57Â %
35.01Â %
0.0160
Lack of efficacy
25.71Â %
23.53Â %
0.3475
Adverse events
7.14Â %
12.04Â %
0.1176
Other causes
18.57Â %
29.41Â %
0.0318